Researchers launch study on Ebola treatments as Congo outbreak worsens

Researchers in Congo began testing two potential Ebola treatments, remdesivir and MBP134, to address the worsening Bundibugyo virus outbreak, which has infected over 1,400 people and caused 438 deaths. The World Health Organization (WHO) is leading the trial, which aims to determine if these drugs improve survival rates in combination with standard care. The study involves collaboration with Congo’s INRB, Oxford University, and other international health groups.